1107 15-year outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma (NMIBC) treated with 5 weekly mitomycin C (MMC) instillations followed by monthly Bacillus-Calmette Guerin (BCG) or alternating BCG and interferon-α2b (IFN) instillations

Muscle Invasive ◽

Re: Long-Term Outcome of Patients with Frequently Recurrent Non-Muscle-Invasive Bladder Carcinoma Treated with One Perioperative plus Four Weekly Instillations of Mitomycin C followed by Monthly bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study

10.1016/j.juro.2016.12.044 ◽

2017 ◽

Vol 197 (3 Part 1) ◽

pp. 605-606

Author(s):

Sam S. Chang

Keyword(s):

Mitomycin C ◽

Bladder Carcinoma ◽

Term Outcome ◽

Long Term Outcome ◽

Muscle Invasive ◽

Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study

European Urology ◽

10.1016/j.eururo.2015.02.022 ◽

2015 ◽

Vol 68 (4) ◽

pp. 611-617 ◽

Cited By ~ 18

Author(s):

Riikka Järvinen ◽

Timo Marttila ◽

Eero Kaasinen ◽

Erkki Rintala ◽

Sirpa Aaltomaa ◽

...

Keyword(s):

Mitomycin C ◽

Bladder Carcinoma ◽

Term Outcome ◽

Long Term Outcome ◽

Muscle Invasive ◽

WEEKLY MITOMYCIN C FOLLOWED BY MONTHLY BACILLUS CALMETTE-GUERIN OR ALTERNATING MONTHLY INTERFERON-α2B AND BACILLUS CALMETTE-GUERIN FOR PROPHYLAXIS OF RECURRENT PAPILLARY SUPERFICIAL BLADDER CARCINOMA

10.1016/s0022-5347(05)67446-0 ◽

2000 ◽

Vol 164 (1) ◽

pp. 47-52 ◽

Cited By ~ 27

Author(s):

EERO KAASINEN ◽

ERKKI RINTALA ◽

ANNA-KAISA PERE ◽

JUKKA KALLIO ◽

VELI-MATTI PUOLAKKA ◽

...

Keyword(s):

Mitomycin C ◽

Bladder Carcinoma ◽

Superficial Bladder Carcinoma ◽

Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer

10.1016/j.juro.2018.06.043 ◽

2018 ◽

Vol 200 (4) ◽

pp. 696-697

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Randomised Controlled Trial ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽

Randomised Controlled

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247–56

European Urology ◽

10.1016/j.eururo.2009.10.033 ◽

2010 ◽

Vol 57 (2) ◽

pp. e7-e9 ◽

Cited By ~ 2

Author(s):

Donald Lamm ◽

Andreas Böhle ◽

Joan Palou ◽

Raj Persad ◽

Maurizio Brausi ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Individual Patient Data ◽

Meta Analysis ◽

Term Outcome ◽

Long Term Outcome ◽

PD19-07 ONE-YEAR FOLLOW-UP RESULTS AFTER SEQUENTIAL INTRAVESICAL BACILLUS CALMETTE-GUÉRIN AND DEVICE-ASSISTED CHEMO-HYPERTHERMIA (MITOMYCIN C DELIVERED BY THE COMBAT BRS SYSTEM) FOR HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS...A BACILLUS CALMETTE-GUÉRIN-SPARING STRATEGY

10.1016/j.juro.2017.02.880 ◽

2017 ◽

Vol 197 (4S) ◽

Cited By ~ 1

Author(s):

TR Leyshon Griffiths ◽

William JF Green ◽

Peter T Grice ◽

Jonathan C Goddard ◽

Roger C Kockelbergh

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

One Year

Bacillus Calmette-Guérin versus Mitomycin C for the Treatment of Intermediate-Risk Non–Muscle-Invasive Bladder Cancer: The Debate Continues

European Urology ◽

10.1016/j.eururo.2009.04.043 ◽

2009 ◽

Vol 56 (2) ◽

pp. 266-268 ◽

Cited By ~ 6

Author(s):

Richard J. Sylvester

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy

Transplant International ◽

10.1111/tri.12484 ◽

2014 ◽

Vol 28 (2) ◽

pp. 199-205 ◽

Cited By ~ 12

Author(s):

Thierry Roumeguère ◽

Nilufer Broeders ◽

Avinash Jayaswal ◽

Sandrine Rorive ◽

Thierry Quackels ◽

...

Keyword(s):

Renal Transplantation ◽

Bladder Carcinoma ◽

Aristolochic Acid ◽

Aristolochic Acid Nephropathy ◽

Muscle Invasive ◽

End Stage

1658 EFFICACY OF IMMEDIATE POST-TUR MITOMYCIN-C (MMC) INSTILLATION IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUERIN (BCG)

10.1016/j.juro.2011.02.1768 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Moon-Ki Jo ◽

Kanghyon Song ◽

Jong-Wook Park

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Carcinoma

European Urology ◽

10.1016/j.eururo.2007.02.063 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1123-1130 ◽

Cited By ~ 82

Author(s):

Martin G. Friedrich ◽

Uwe Pichlmeier ◽

Hartwig Schwaibold ◽

Stefan Conrad ◽

Hartwig Huland

Keyword(s):

Adjuvant Chemotherapy ◽

Recurrence Rate ◽

Bladder Carcinoma ◽

Intravesical Chemotherapy ◽

Term Therapy ◽

Short Term ◽

Short Term Therapy ◽